BIOCRYST PHARMACEUTICALS, INC. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 59.00 thousand shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2024-02-27
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2023 was 59.00K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|
| 2023-12-31 | 59.00K shares 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |